An Examination of the Application of Cannabis in Therapeutic Use for Parkinson's syndrome

• Caiza Asitimbay, Mónica Alexandra ^[1] ; Kapoor, Tarun ^[2] ; Maqsood, Ramish ^[3] ; Reddy, Pramod ^[4] ; Sahoo, Lulup Kumar ^[5] ; Aggarwal, Prateek ^[6]
  1. [1] Universidad Nacional de Chimborazo, Breve descripción: Médico General, Especialista en Reumatología y Medicina Legal. Docente Investigador, Riobamba - Ecuador
  2. [2] Centre of Research Impact and Outcome, Chitkara University, Rajpura- 140417, Punjab, India
  3. [3] Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida, Uttar Pradesh, India
  4. [4] Centre for Multidisciplinary Research, Anurag University, Hyderabad, Telangana, India
  5. [5] Department of Neurology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
  6. [6] Chitkara Centre for Research and Development, Chitkara University, Himachal Pradesh-174103 India

  Mostrar afiliaciones +
• Localización: Health Leadership and Quality of Life, ISSN-e 3008-8488, Vol. 4, Nº. 0, 2025
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • The consequences of cannabis usage on Multiple Sclerosis (MS) and Parkinson's disease (PD) are still substantially uncertain despite recognizing that Cannabis was used for thousands of years as a medication. The evaluation of cannabis usage PD and MS, and a comparison of cannabis users' and non-users' self-reported assessments of neurological impairment were primary goals of this research. The survey contained standardized questions to collect information on demographics and Cannabis use questionnaires to evaluate participants' physical activity levels, neurological function, and weariness. Linear regression, Hierarchical Regression, and ANCOVA analysis of variance were employed in research. Were 900 respondents in a final data set. Cannabis consumers today were younger and less inclined to be considered fat. Regarding Emotional Variability, Cognitive Function, and Fatigue, cannabis users reported decreased degrees of disability. Cannabis may benefit PD and MS patients' Emotional Variability, Cognitive Function, Fatigue, and Physiological Weight. PD and MS patients' cannabis use: long-term advantages and downsides, and determining if these relationships are causal, more research is required to utilize longitudinally and clinically measured assessments among these domains.